Company intelligence / Profile preview

Wuling Biotechnology

Fuzhou, Fujian, China

Ownership: Private
Development stage: Other

Overview

Wuling is a leading supplier of organic medicinal mushroom products, with a global export business and collaborations with major Chinese academic institutions. The focus is on proprietary cultivation and advanced extraction of Reishi, Lion's Mane, Cordyceps, and other mushrooms. The company's products are used for health support, immune modulation, and functional food applications, but do not appear to have formal clinical trial results for registered drugs.

Therapeutic areas: ImmunologyNeurologyPsychiatryOther
Modalities: Plant extractFunctional foodNutraceutical
Industry: Food & Nutrition

Partnerships

Shanghai Fudan UniversityInstitute of Chinese Medicine of Beijing 302 HospitalPeking University Health Science CenterJuncao Biology Institute of Fujian Agriculture and Forestry University

Beyond the preview

Go deeper on Wuling Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuling Biotechnology.

Explore the full profile